LYKALABS vs VINEETLAB: Stock Comparison

Lyka Labs Limited vs Vineet Laboratories Limited

Live data: 1 July 2026, 4:08 PM IST • Source: NSE and company filings

Lyka Labs Limited is the larger company by market capitalisation. Lyka Labs Limited shows lower leverage, a higher ROCE and a higher net margin, while Vineet Laboratories Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Lyka Labs Limited and Vineet Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, LYKALABS is more favourable on 6 of 10 scored metrics and VINEETLAB on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
LYKALABS is the larger company
₹225 Cr vs ₹75 Cr
EPS
LYKALABS has higher earnings per share
₹-2.81 vs ₹-20.47
Revenue Growth (TTM YoY)
VINEETLAB has faster revenue growth
11.05% vs 0%
Qtr Sales Growth
LYKALABS has stronger quarterly sales growth
9.7% vs -68.8%
Qtr Profit Growth
VINEETLAB has stronger quarterly profit growth
59.2% vs -35.4%
ROCE
LYKALABS has a higher ROCE
9.91% vs -28%
Net Margin
LYKALABS has a higher net margin
-7.81% vs -26.92%
Operating Margin
LYKALABS has a higher operating margin
-9.43% vs -22.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLYKALABSVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricLYKALABSVINEETLAB
Live Price₹74.83₹38.55
Day Change1.19%5.79%
Volume88,5562.02 L
52-Week High₹121.44₹49.99
52-Week Low₹44.1₹27.96
Distance from 52W High-38.38%-22.88%

Valuation

MetricLYKALABSVINEETLAB
Market Cap₹225 Cr₹75 Cr
P/E Ratio-20.64x
P/B Ratio2.24x
EPS₹-2.81₹-20.47
Book Value₹25.87₹15.84
Dividend Yield0%0%

Growth

MetricLYKALABSVINEETLAB
Revenue Growth (TTM YoY)0%11.05%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth9.7%-68.8%
Qtr Profit Growth-35.4%59.2%

Profitability & Leverage

MetricLYKALABSVINEETLAB
ROE0%
ROCE9.91%-28%
Net Margin-7.81%-26.92%
Operating Margin-9.43%-22.4%
Debt to Equity0x2.73x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricLYKALABSVINEETLAB
Promoter Holding58.45% 0.29 pp5.98% 6.48 pp
FII Holding0.17% 0.12 pp0.36% 0.36 pp
DII Holding0.66% 0.01 pp
Public Holding40.72% 0.16 pp93.66% 6.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Lyka Labs Limited and Vineet Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.